Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2025)

Benitec Biopharma's Other Operating Expenses history spans 6 years, with the latest figure at $1.9 million for Q4 2024.

  • For Q4 2024, Other Operating Expenses rose 188100.0% year-over-year to $1.9 million; the TTM value through Mar 2025 reached $1.9 million, up 1842.59%, while the annual FY2024 figure was -$108000.0, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2024 was $1.9 million at Benitec Biopharma, up from -$3000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.9 million in Q4 2024 and bottomed at -$215000.0 in Q2 2020.
  • The 5-year median for Other Operating Expenses is $1000.0 (2021), against an average of $166666.7.
  • The largest annual shift saw Other Operating Expenses crashed 114.29% in 2022 before it soared 188100.0% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$19000.0 in 2020, then soared by 105.26% to $1000.0 in 2021, then skyrocketed by 800.0% to $9000.0 in 2022, then plummeted by 88.89% to $1000.0 in 2023, then skyrocketed by 188100.0% to $1.9 million in 2024.
  • Per Business Quant, the three most recent readings for BNTC's Other Operating Expenses are $1.9 million (Q4 2024), -$3000.0 (Q1 2024), and $1000.0 (Q4 2023).